Faculty
Camille Abboud.jpg

Camille N. Abboud, MD

Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia

Clinical Interests

  • Acute & chronic leukemia
  • Myelodysplastic syndrome
  • Myeloproliferative disorders
  • Lymphoma
  • Myeloma

Contact

  • 314-747-8439 (tel)
  • 314-454-7551 (fax)
  • 14th Floor Northwest Tower (office)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Biosketch

Education
1970 BS (with honors), American University of Beirut, Lebanon
1974 MD, American University of Beirut School of Medicine, Lebanon
Post-graduate Training
1973-1974 Straight Medical Intern, American University Hospital, Beirut
1974-1976 Resident in Medicine, College of Medicine & Dentistry of New Jersery and Rutgers Medical School, Piscataway, NJ
1976-1977 Clinical Fellow in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
1977-1979 Research Fellow in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
1979-1980 Senior Instructor in Hematology, Department of Medicine, University of Rochester School of Medicine, Rochester, NY
Academic Positions & Employment
1976-1979 Instructor in Medicine, University of Rochester, Rochester, NY
1979-1980 Senior Instructor in Medicine, University of Rochester, Rochester, NY
1980-1986 Assistant Professor of Medicine, University of Rochester, Rochester, NY
1986-1995 Associate Professor of Medicine, University of Rochester, Rochester, NY
1995-2007 Professor of Medicine, University of Rochester, Rochester, NY
2007-present Professor of Medicine, Washington University School of Medicine, St. Louis, MO
Board Certification
1976 American Board of Internal Medicine
1978 Hematology (ABIM)
Honors & Awards
1977-1979 NIH Training Grant, University of Rochester
1981-1982 Sinsheimer Award, University of Rochester
1982 Bushwell Fellow, University of Rochester
Editorial Boards
1992-1994 Editorial Board, Experimental Hematology
2009-present Editorial Board, Advances in Hematology
Advisory & Peer-review Committees
1985, 1987 ACS Advisory Committee on Clinical Investigations II - Chemotherapy and Hematology (ad hoc member)
1990 National Institute of Health Lung and Blood (reviewer), Stem Cell Biology RFA
1992 National Institute of Health Lung and Blood (reviewer), Sickle Cell Center
1992 ACS Advisory Committee on Drug Development, Hematology and Pathology
1992, 1994 NIH, DRG, ad hoc reviewer K21 grants
1994 American Cancer Society (outside ad hoc reviewer), Immunology Section
1994 NIHLB and NIADDK (reviewer), "In-Utero Transplantation" RFA and "Hematologic Consequences of HIV Infection of Marrow Cells" RFA-HL-94-04-B
1995 NIHLB: "Cytokine Effects on Hematopoiesis in AIDS Animal Models", RFA-HL-95-09B
1995 NIHLB (reviewer): SCORs on Stem Cell Biology, RFA-NIH-94-HL-10-B
1995 American Cancer Society Immunology Study Section (reviewer)
1995 NIHLB, ad hoc reviewer for PO1 on Stem Cells, Johns Hopkins site visit
1995-2001 Armed Forces Breast Cancer Grants, "Pathobiology panel" (ad hoc reviewer)
1995-2000 Member, Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) Inspection Committee
1996 NIHLB, ad hoc reviewer for PO1 on Stem Cells and Cell Cycle, Bethesda
1996 NCI, "Studies of the Viral Etiology of AIDS-Associated Malignancies", RFA #CA-96-08
1997 NIHLBI, NIDDK, "Homing of Stem/Progenitor Cells", Bethesda, RFA #HLA-96-020
1997 NIHLBI, "Gene Transfer Principles of Heart, Lung, and Blood Diseases", RFA #HL-96-019
1997 NCI, reviewer of PO1, "Breast Cancer Chemotherapy and Vaccines"
1998 NIHLBI, "A Related Umbilical Cord Blood Bank for Hemoglobinopathy Patients", Chairman
1998-1991 ACS Advisory Committee on Clinical Investigations II - Chemotherapy and Hematology (full member)
2003-2004 NCI, Clinical Oncology Study Section, Quick Trials for Novel Cancer Therapies, reviewer
2004 NIAID, reviewer of PO1, "Myeloid Progenitor Cell Therapy for Radiation Exposure"
2005 NCI, reviewer of Centers for Medical Countermeasures Against Radiation
2005 NCI, PO1 reviewer, Gene Therapy Cluster Review, Cellular Transduction in Cancer
2007-present Leukemia & Lymphoma Society, Translational Review Panel
2008 NCI, reviewer, "Tumor Stem Cells in Cancer Biology, Prevention, and Therapy", RO1, RFA: CA 08-019
2008 NCI, reviewer, "Tumor Stem Cells in Cancer Biology, Prevention, and Therapy", RO1, RFA: CA 08-020
2009 NIAID, reviewer of RFP-NIAID-DAIT-NIHAI2008023, "Studies of Immunosenescence and Other Late Effects of Acute Ionizing Radiation Exposure in Atomic Bomb Survivors"
2009 NCI- ARRA Grand Opportunities- "Stem Cells/Cell Biology", Ad Hoc reviewer
2009-present ASH Scholar Award Study Section member
2010 NCI Cancer Center Grant, Ad Hoc reviewer
2010-present NCCN Acute Myeloid Leukemia Panel Member
2010-present NCCN Chronic Myelogenous Leukemia Panel Member
2012 NIAID, reviewer of RFA-NIH-NIAID-DAIT-11-033, "Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries"
2013 NIAID, reviewer of RFA-AI-12-023, "Development of Medical Countermeasures for Post-Exposure Mitigation/Treatment of Injuries Resulting from a Radiation/Nuclear Incident" (UO1)
2016 NIAID-DAIT-NIH-AI-2015042 BAA, "Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Devices", reviewer
Professional Societies & Organizations
1979-present American College of Physicians
1980-2004 American Association for the Advancement of Science
1980-2004 American Federation for Clinical Research
1980-present International Society for Experimental Hematology
1981-present American Society of Hematology
1990-2004 Society of Leukocyte Biology
1992-present American Society of Clinical Oncology
1993-present International Society for Cellular Therapy (formerly ISAGE)
1994-present American Society for Blood & Marrow Transplantation
1996-present American Association of Cancer Research